Orchard Therapeutics develops curative gene therapies for genetic diseases using hematopoietic stem cells.
The Medical Science Liaison (MSL) will be responsible for developing and enhancing professional relationships with external thought leaders in the field of gene therapy. The MSL will be a therapeutic and disease area scientific expert and will work closely with the medical affairs team to provide timely and accurate information to healthcare providers and key external experts.
Orchard Therapeutics develops curative gene therapies for genetic diseases using hematopoietic stem cells.
Baylor Genetics